{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T02:36:28Z","timestamp":1773887788668,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010804","name":"Prince of Songkla University Faculty of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010804","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmdjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Molecular Diagnostics"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jmoldx.2025.10.001","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:10:03Z","timestamp":1761696603000},"page":"112-123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical Utility and Performance of Methylation-Specific Triplet-Primed PCR for Fragile X Syndrome Diagnosis"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3245-4627","authenticated-orcid":false,"given":"Areerat","family":"Hnoonual","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wipawan","family":"Arunthong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oradawan","family":"Plong-on","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pornsiri","family":"Sangmanee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pornprot","family":"Limprasert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmoldx.2025.10.001_bib1","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/gim.2013.61","article-title":"ACMG Standards and Guidelines for fragile X testing: a revision to the disease-specific supplements to the Standards and Guidelines for Clinical Genetics Laboratories of the American College of Medical Genetics and Genomics","volume":"15","author":"Monaghan","year":"2013","journal-title":"Genet Med"},{"key":"10.1016\/j.jmoldx.2025.10.001_bib2","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/ajmg.a.36511","article-title":"Epidemiology of fragile X syndrome: a systematic review and meta-analysis","volume":"164A","author":"Hunter","year":"2014","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jmoldx.2025.10.001_bib3","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1007\/s10815-024-03242-2","article-title":"Population-based FMR1 carrier screening among reproductive women","volume":"41","author":"Ain","year":"2024","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.jmoldx.2025.10.001_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-77762-3","article-title":"Prevalence and implications of fragile X premutation screening in Thailand","volume":"14","author":"Hnoonual","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.jmoldx.2025.10.001_bib5","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41436-021-01115-y","article-title":"Laboratory testing for fragile X, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG)","volume":"23","author":"Spector","year":"2021","journal-title":"Genet Med"},{"key":"10.1016\/j.jmoldx.2025.10.001_bib6","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/ajmg.a.35833","article-title":"Fragile X AGG analysis provides new risk predictions for 45-69 repeat alleles","volume":"161A","author":"Nolin","year":"2013","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jmoldx.2025.10.001_bib7","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/gim.2012.34","article-title":"AGG interruptions within the maternal FMR1 gene reduce the risk of offspring with fragile X syndrome","volume":"14","author":"Yrigollen","year":"2012","journal-title":"Genet Med"},{"key":"10.1016\/j.jmoldx.2025.10.001_bib8","doi-asserted-by":"crossref","first-page":"9206","DOI":"10.3390\/ijms24119206","article-title":"Narrative review: update on the molecular diagnosis of fragile X syndrome","volume":"24","author":"Ciobanu","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jmoldx.2025.10.001_bib9","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jmoldx.2019.11.002","article-title":"Validation of fragile X screening in the newborn population using a fit-for-purpose FMR1 PCR assay system","volume":"22","author":"Lee","year":"2020","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2025.10.001_bib10","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/gm401","article-title":"FMR1 CGG allele size and prevalence ascertained through newborn screening in the United States","volume":"4","author":"Tassone","year":"2012","journal-title":"Genome Med"},{"key":"10.1016\/j.jmoldx.2025.10.001_bib11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2353\/jmoldx.2008.070073","article-title":"A rapid polymerase chain reaction-based screening method for identification of all expanded alleles of the fragile X (FMR1) gene in newborn and high-risk populations","volume":"10","author":"Tassone","year":"2008","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2025.10.001_bib12","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1586\/14737159.2015.1101348","article-title":"Advanced technologies for the molecular diagnosis of fragile X syndrome","volume":"15","author":"Tassone","year":"2015","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.jmoldx.2025.10.001_bib13","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3343\/alm.2021.41.4.394","article-title":"Accuracy and performance evaluation of triplet repeat primed PCR as an alternative to conventional diagnostic methods for fragile X syndrome","volume":"41","author":"Gu","year":"2021","journal-title":"Ann Lab Med"},{"key":"10.1016\/j.jmoldx.2025.10.001_bib14","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jmoldx.2021.11.007","article-title":"High-throughput methylation-specific triplet-primed PCR and melting curve analysis for selective and reliable identification of actionable FMR1 genotypes","volume":"24","author":"Rajan-Babu","year":"2022","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2025.10.001_bib15","doi-asserted-by":"crossref","first-page":"589","DOI":"10.2353\/jmoldx.2010.090227","article-title":"An information-rich CGG repeat primed PCR that detects the full range of fragile X expanded alleles and minimizes the need for southern blot analysis","volume":"12","author":"Chen","year":"2010","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2025.10.001_bib16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3390\/genes7100087","article-title":"Molecular correlates and recent advancements in the diagnosis and screening of FMR1-related disorders","volume":"7","author":"Rajan-Babu","year":"2016","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.jmoldx.2025.10.001_bib17","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1586\/14737159.2015.1001749","article-title":"Single-tube methylation-specific duplex-PCR assay for rapid and accurate diagnosis of fragile X mental retardation 1-related disorders","volume":"15","author":"Rajan-Babu","year":"2015","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.jmoldx.2025.10.001_bib18","doi-asserted-by":"crossref","first-page":"143","DOI":"10.11622\/smedj.2020009","article-title":"Repeat expansion and methylation-sensitive triplet-primed polymerase chain reaction for fragile X mental retardation 1 gene screening in institutionalised intellectually disabled individuals","volume":"62","author":"Sihombing","year":"2021","journal-title":"Singapore Med J"},{"key":"10.1016\/j.jmoldx.2025.10.001_bib19","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1373\/clinchem.2013.206771","article-title":"Methylation-specific triplet-primed PCR and melting curve analysis as a rapid screening tool for identifying actionable FMR1 genotypes","volume":"59","author":"Teo","year":"2013","journal-title":"Clin Chem"},{"key":"10.1016\/j.jmoldx.2025.10.001_bib20","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3389\/fgene.2014.00318","article-title":"Clinical and molecular implications of mosaicism in FMR1 full mutations","volume":"5","author":"Pretto","year":"2014","journal-title":"Front Genet"},{"key":"10.1016\/j.jmoldx.2025.10.001_bib21","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3389\/fgene.2018.00173","article-title":"Health profiles of mosaic versus non-mosaic FMR1 premutation carrier mothers of children with fragile X syndrome","volume":"9","author":"Mailick","year":"2018","journal-title":"Front Genet"},{"key":"10.1016\/j.jmoldx.2025.10.001_bib22","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/GIM.0b013e3181d0d40e","article-title":"Qualitative assessment of FMR1 (CGG)n triplet repeat status in normal, intermediate, premutation, full mutation, and mosaic carriers in both sexes: implications for fragile X syndrome carrier and newborn screening","volume":"12","author":"Hantash","year":"2010","journal-title":"Genet Med"},{"key":"10.1016\/j.jmoldx.2025.10.001_bib23","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1080\/14737159.2017.1377612","article-title":"Size and methylation mosaicism in males with fragile X syndrome","volume":"17","author":"Jiraanont","year":"2017","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.jmoldx.2025.10.001_bib24","doi-asserted-by":"crossref","first-page":"904","DOI":"10.3390\/brainsci11070904","article-title":"The impact of X-chromosome inactivation on phenotypic expression of X-linked neurodevelopmental disorders","volume":"11","author":"Brand","year":"2021","journal-title":"Brain Sci"},{"key":"10.1016\/j.jmoldx.2025.10.001_bib25","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/ajmg.a.20160","article-title":"Fragile-X syndrome and skewed X-chromosome inactivation within a family: a female member with complete inactivation of the functional X chromosome","volume":"122A","author":"Heine-Su\u00f1er","year":"2003","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jmoldx.2025.10.001_bib26","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1002\/1522-2683(20017)22:11<2150::AID-ELPS2150>3.0.CO;2-U","article-title":"Electrophoretic migration behavior of DNA fragments in polymer solution","volume":"22","author":"Jin","year":"2001","journal-title":"Electrophoresis"},{"key":"10.1016\/j.jmoldx.2025.10.001_bib27","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/elps.200390054","article-title":"Anomalously fast migration of triplet-repeat DNA in capillary electrophoresis with linear polymer solution","volume":"24","author":"Kiba","year":"2003","journal-title":"Electrophoresis"},{"key":"10.1016\/j.jmoldx.2025.10.001_bib28","doi-asserted-by":"crossref","DOI":"10.1017\/erm.2017.10","article-title":"FMR1 CGG repeat expansion mutation detection and linked haplotype analysis for reliable and accurate preimplantation genetic diagnosis of fragile X syndrome","volume":"19","author":"Rajan-Babu","year":"2017","journal-title":"Expert Rev Mol Med"}],"container-title":["The Journal of Molecular Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157825002533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157825002533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T21:59:50Z","timestamp":1773871190000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525157825002533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1525157825002533"],"URL":"https:\/\/doi.org\/10.1016\/j.jmoldx.2025.10.001","relation":{},"ISSN":["1525-1578"],"issn-type":[{"value":"1525-1578","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Utility and Performance of Methylation-Specific Triplet-Primed PCR for Fragile X Syndrome Diagnosis","name":"articletitle","label":"Article Title"},{"value":"The Journal of Molecular Diagnostics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmoldx.2025.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Association for Molecular Pathology and American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}